English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

8. Kaiser C, Kuster GM, Erne P et al. Risks and benefits of optimised medical and revascularisation therapy in elderly patients with anginaon-treatment analysis of the TIME trial. Eur Heart J 2004; 25: 1036–42. 9. Claude J, Schindler C, Kuster GM et al. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Eur Heart J 2004; 25: 2195–203. 10. Stone PH, Thompson B, Anderson V et al. Influence of race, sex, and age on management of unstable angina and non-Q wave myocardial infarction. The TIMI-III registry. JAMA 1996; 275: 1104–12. 11. Collinson J, Flather MD, Fox KAA et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). Eur Heart J 2000; 21: 1450–57. 12. De Gregorio J, Kobayashi Y, Albiero R et al. Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow up. J Am Coll Cardiol 1998; 32: 577–83. 13. Maurer MS. Age: a nonmodifiable risk factor? J Coll Cardiol 2003; 42: 1427–8. 14. Bowling A. Ageism in cardiology. BMJ 1999; 319: 1353–5. 15. Graham MM, Ghali WA, Faris PD et al. Survival after coronary revascularisation in the elderly. Circulation 2002; 105: 2378–84. 16. Floyd KC, Jayne JE, Kaplan AV et al. Age-based differences of percutaneous intervention in the drug-eluting stent era. J Interven Cardiol 2006; 19: 381–7. 17. Spertus JA, Kettelkamp R, Vance C et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Circulation 2006; 113: 2803–9.

Postoperative myocardial damages after hip fracture repair are frequent and associated with a poor cardiac outcome: a three-hospital study